Showing results (201-210 of 305) with videos related to
Sort By:
Pageof 31
Cancer Gene Therapy|January 23, 1999
Retroviral vector-mediated transfer of the interferon-alpha gene in chronic myeloid leukemia cellsS Salesse, F Moreau-Gaudry, V Pigeonnier-Lagarde, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.Leukemia|August 11, 1998
Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoidsB Jazwiec, A Solanilla, C Grosset, et al.Blood|April 1, 1987
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow TransplantationG Gahrton, S Tura, M Flesch, et al.Leukemia & Lymphoma|March 18, 2000
Intrasinusoidal bone marrow infiltration revealing intravascular lymphomatosisM Parrens, P Dubus, P Agape, et al.International Journal of Radiation Oncology, Biology, Physics|February 1, 1995
Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de MoelleM Resbeut, D Cowen, D Blaise, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1991
Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. The Groupe d'Etude des greffes de moelle osseuse (GEGMO)G Socie, A Devergie, T Girinsky, et al.The British Journal of Dermatology|December 3, 1999
Meningeal involvement by a transformed mycosis fungoides following Hodgkin's diseaseM Beylot-Barry, P Dubus, B Vergier, et al.American Journal of Hematology|February 14, 1998
Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein compositionL Macchi, P Nurden, G Marit, et al.Bone Marrow Transplantation|July 1, 1989
Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host diseaseG Laurent, D Maraninchi, E Gluckman, et al.Pageof 31